The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Coenzyme Q 10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects
Open accessAbstract
Coenzyme Q 10 is an essential cofactor of the electron transport chain as well as a potent free radical scavenger in lipid and mitochondrial membranes. Feeding with coenzyme Q 10 increased cerebral cortex concentrations in 12- and 24-month-old rats. In 12-month-old rats administration of coenzyme Q 10 resulted in significant increases in cerebral cortex mitochondrial concentrations of coenzyme Q 10 . Oral administration of coenzyme Q 10 markedly attenuated striatal lesions produced by systemic administration of 3-nitropropionic acid and significantly increased life span in a transgenic mouse model of familial amyotrophic lateral sclerosis. These results show that oral administration of coenzyme Q 10 increases both brain and brain mitochondrial concentrations. They provide further evidence that coenzyme Q 10 can exert neuroprotective effects that might be useful in the treatment of neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We also demonstrated that CoQ10 produces neuroprotective effects in transgenic mouse models of ALS and HD150, 151.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [150]
In the citing paper
“Oral administration of CoQ10 exerts significant neuroprotective effects against striatal lesions in rats produced by aminoxyacetic acid, and the mitochondrial toxins malonate and 3-NP148-150.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [150]
In the citing paper
“Similarly, oral administration of CoQ10 for 1 week, prior to administration of 3-NP resulted in a significant 90% neuroprotection against 3-NP induced striatal lesions150.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [150]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062
Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation
Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143
Wong, P. C., Pardo, C. A., Borchelt, D., Lee, M. K., Copeland, N. G., Jenkins, N. A., Sisodia, S. S., Cleveland, D. W., & Price, D. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90259-7 · Cited by 1,439
Aging, energy, and oxidative stress in neurodegenerative diseases
Beal, M. F. (1995) · Annals of Neurology · doi:10.1002/ana.410380304 · Cited by 1,434
Self-citationBruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341
Biochemical, physiological and medical aspects of ubiquinone function
Ernster, L., & Dallner, G. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00028-3 · Cited by 1,246
Beal, M. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310202 · Cited by 962
Self-citationGurney, M. E., Cutting, F. B., Zhai, P., Doble, A., Taylor, C. P., Andrus, P. K., & Hall, E. D. (1996) · Annals of Neurology · doi:10.1002/ana.410390203 · Cited by 647
Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations.
Frei, B. B., Kim, M. C., & Ames, B. N. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4879 · Cited by 623
Cortical Cytochrome Oxidase Activity Is Reduced in Alzheimer's Disease
Mutisya, E. M., Bowling, A. C., & Beal, M. F. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63062179.x · Cited by 531
Self-citation
Flagged first, then by citations
Research works printed but not linked: 6
- S Sugiyama, K Yamada, T Ozawa Biochem Mol Biol Int 37, 1111–1120 (1995).
- A Sanbe, K Tanonaka, Y Niwano, S Takeo J Pharmacol Exp Ther 269, 51–56 (1994).
- S Takeo, K Tanonaka, T Tazuma, K Miyake, R Murai J Pharmacol Exp Ther 243, 1131–1138 (1987).
- T Nakamura, H Sanma, M Himeno, K Kato Transfer of Exogenous Coenzyme Q to Inner Membrane of Heart Mitochondria in Rats, eds Y Yamamura, K Folkers, Y Ito (Elsevier, Amsterdam) 2, 3–11 (1989).
- V Valls, C Castelluccio, R Fato, M L Genova, C Bovina, G Saez, M Marchetti, P Castelli, G Lenaz Biochem Mol Biol Int 33, 633–642 (1994).
- S Reahal, J Wrigglesworth Drug Metab Dispos 20, 423–427 (1992).
Cited by
Sorted by citations
Items 201–300 of 556
The emerging role of cardiovascular risk factor-induced mitochondrial dysfunction in atherogenesis
Puddu, P., Puddu, G. M., Cravero, E., Pascalis, S. D., & Muscari, A. (2009) · Journal of Biomedical Science · doi:10.1186/1423-0127-16-112 · Cited by 65
Targets in ALS: designing multidrug therapies
Carrı̀, M. T., Grignaschi, G., & Bendotti, C. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.03.009 · Cited by 63
Current and emerging treatments for amyotrophic lateral sclerosis
Zoccolella (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s7788 · Cited by 62
CoQ10 deficiency diseases in adults
Quinzii, C. M., Hirano, M., & DiMauro, S. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.03.004 · Cited by 62
Rajdev, K., Siddiqui, E. M., Jadaun, K. S., & Mehan, S. (2020) · IBRO Reports · doi:10.1016/j.ibror.2020.03.001 · Cited by 61
Plant Derived Phytocompound, Embelin in CNS Disorders: A Systematic Review
Kundap, U. P., Bhuvanendran, S., Kumari, Y., Othman, I., & Shaikh, M. F. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00076 · Cited by 62
Coenzyme Q10 effects in neurological diseases
Rauchová, H. (2021) · Physiological Research · doi:10.33549/physiolres.934712 · Cited by 68
Nicolson, G. L., & Ellithorpe, R. R. (2006) · Journal of Chronic Fatigue Syndrome · doi:10.1300/j092v13n01_06 · Cited by 59
Effects of Coenzyme Q10 in Huntington's disease and early Parkinson's disease
Beal, M. F., & Shults, C. W. (2003) · BioFactors · doi:10.1002/biof.5520180218 · Cited by 60
Self-citationNeuroprotection: is it already applicable to glaucoma therapy?
Ritch, R. H. (2000) · Current Opinion in Ophthalmology · doi:10.1097/00055735-200004000-00002 · Cited by 58
Friedreich’s ataxia: Coenzyme Q10 and vitamin E therapy
Cooper, J. A. D., & Schapira, A. H. V. (2007) · Mitochondrion · doi:10.1016/j.mito.2007.04.001 · Cited by 58
Protection by thiols of the mitochondrial complexes from 4-hydroxy-2-nonenal
Korotchkina, L. G., Yang, H., Tirosh, O., Packer, L., & Patel, M. S. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00491-9 · Cited by 57
Improvement in Intestinal Coenzyme Q10 Absorption by Food Intake
Ochiai, A., Itagaki, S., Kurokawa, T., Kobayashi, M., Hirano, T., & Iseki, K. (2007) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.127.1251 · Cited by 60
Tkáč, I., Keene, C. D., Pfeuffer, J., Low, W. C., & Rolf Gruetter, A. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.10112 · Cited by 57
Pathophysiological targets for non-pharmacological treatment of migraine
Coppola, G., Lorenzo, C. D., Serrao, M., Parisi, V., Schoenen, J. E., & Pierelli, F. (2015) · Cephalalgia · doi:10.1177/0333102415620908 · Cited by 56
Huntington’s disease: the coming of age
Pandey, M., & Rajamma, U. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0957-1 · Cited by 56
Therapeutic Effects of Coenzyme Q10 in Neurodegenerative Diseases
Beal, M. F. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)82026-3 · Cited by 55
Self-citationMitochondrial dysfunction in psychiatric disorders
Ni, P., Ma, Y., & Chung, S. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.08.027 · Cited by 61
Nutritional and exercise-based interventions in the treatment of amyotrophic lateral sclerosis
Patel, B. P., & Hamadeh, M. J. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.06.002 · Cited by 55
Coenzyme Q10 Metabolism: A Review of Unresolved Issues
Mantle, D., López‐Lluch, G., & Hargreaves, I. P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032585 · Cited by 59
Mitochondrial Toxin 3-Nitropropionic Acid Induces Cardiac and Neurotoxicity Differentially in Mice
Gabrielson, K. L., Hogue, B. A., Bohr, V. A., Cardounel, A. J., Nakajima, W., Kofler, J., Zweier, J. L., Rodríguez, E. R., Martin, L. J., de Souza-Pinto, N. C., et al. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62536-9 · Cited by 54
Primary coenzyme Q10deficiency and the brain
Naini, A., Lewis, V., Hirano, M., & DiMauro, S. (2003) · BioFactors · doi:10.1002/biof.5520180217 · Cited by 54
Wu, Y., Wu, S., & Wei, Y. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140306103401 · Cited by 55
Oxidative Stress Treatment for Clinical Trials in Neurodegenerative Diseases
Ienco, E. C., LoGerfo, A., Carlesi, C., Orsucci, D., Ricci, G., Mancuso, M., & Siciliano, G. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110164 · Cited by 56
Grazzi, L., Toppo, C., D’Amico, D., Leonardi, M., Martelletti, P., Raggi, A., & Guastafierro, E. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18041503 · Cited by 55
Coenzyme Q10 (Ubiquinol-10) Supplementation Improves Oxidative Imbalance in Children With Trisomy 21
Miles, M. V., Patterson, B. J., Chalfonte-Evans, M., Horn, P. S., Hickey, F. J., Schapiro, M. B., Steele, P. E., Tang, P., & Hotze, S. L. (2007) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2007.08.003 · Cited by 52
McMeekin, L. J., Fox, S. N., Boas, S. M., & Cowell, R. M. (2021) · Cells · doi:10.3390/cells10020352 · Cited by 53
Segatto, M., Manduca, A., Lecis, C., Rosso, P., Jozwiak, A., Swiezewska, E., Moreno, S., Trezza, V., & Pallottini, V. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.284 · Cited by 51
Solanesol: Added value from Solanaceous waste
Taylor, M. A., & Fraser, P. D. (2011) · Phytochemistry · doi:10.1016/j.phytochem.2011.03.015 · Cited by 51
Li, L., Du, J., Lian, Y., Zhang, Y. L., Li, X., Liu, Y., Zou, L., & Wu, T. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0224-4 · Cited by 51
Quiles, J. L., Ochoa, J. J., Battino, M. A., Gutierrez-Ríos, P., Araujo-Nepomuceno, E., López‐Frías, M., Huertas, J. R., & Mataix, J. (2005) · BioFactors · doi:10.1002/biof.5520250109 · Cited by 51
Brooks, B. R. (2009) · Annals of Neurology · doi:10.1002/ana.21544 · Cited by 51
Pharmaceutical, cellular and genetic therapies for Huntington's disease
Handley, O., Naji, J. J., Dunnett, S. B., & Rosser, A. (2005) · Clinical Science · doi:10.1042/cs20050148 · Cited by 51
CoQ10 and Mitochondrial Dysfunction in Alzheimer’s Disease
Fišar, Z., & Hroudová, J. (2024) · Antioxidants · doi:10.3390/antiox13020191 · Cited by 57
Mitochondria-Targeted Antioxidant MitoQ Reduces Gentamicin-Induced Ototoxicity
Ojano-Dirain, C. P., Antonelli, P. J., & Prell, C. G. L. (2014) · Otology & Neurotology · doi:10.1097/mao.0000000000000192 · Cited by 49
The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start?☆
Lee, J.-H., Boo, J. H., & Ryu, H. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.07.016 · Cited by 51
Peng, J.-J., Lin, S.-H., Liu, Y., Lin, H.-C., Li, T.-N., & Yao, C. (2019) · eLife · doi:10.7554/elife.47372 · Cited by 42
Behavioral Improvement after Chronic Administration of Coenzyme Q10 in P301S Transgenic Mice
Elipenahli, C., Stack, C., Jainuddin, S., Gerges, M., Yang, L., Starkov, A. A., Beal, M. F., & Dumont, M. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-111190 · Cited by 49
Self-citationShetty, R. A., Forster, M. J., & Sumien, N. (2013) · AGE · doi:10.1007/s11357-012-9484-9 · Cited by 47
Mao, G., Kraus, G. A., Kim, I., Spurlock, M. E., Bailey, T. B., Zhang, Q., & Beitz, D. C. (2010) · The Journal of Nutrition · doi:10.3945/jn.110.121715 · Cited by 48
Lipid dysfunction and pathogenesis of multiple system atrophy
Bleasel, J. M., Wong, J. H., Halliday, G. M., & Kim, W. S. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-15 · Cited by 47
Prolonged Intake of Coenzyme Q10 Impairs Cognitive Functions in Mice
Sumien, N., Heinrich, K. R., Shetty, R. A., Sohal, R. S., & Forster, M. J. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.110437 · Cited by 46
Management of the aging risk factor for Parkinson's disease
Phillipson, O. T. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.10.073 · Cited by 47
New insights on brain stem death: From bedside to bench
Chan, J. Y. H., Chang, A. Y., & Chan, S. H. H. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.11.004 · Cited by 46
Attia, H. N., & Maklad, Y. A. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000342 · Cited by 46
Sharman, K. G., Sharman, E. H., Yang, E. Y., & Bondy, S. C. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00329-3 · Cited by 46
Quinones in long‐lived clk‐1 mutants of Caenorhabditis elegans
Miyadera, H., Kano, K., Miyoshi, H., Ishii, N., Hekimi, S., & Kita, K. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02282-2 · Cited by 46
Reduced Coenzyme Q10 Supplementation Decelerates Senescence in SAMP1 Mice
Yan, J., Fujii, K., Yao, J., Kishida, H., Hosoe, K., Sawashita, J., Takeda, T., Mori, M., & Higuchi, K. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2005.11.007 · Cited by 45
Coenzyme Q10, Ageing and the Nervous System: An Overview
Mantle, D., Heaton, R. A., & Hargreaves, I. P. (2021) · Antioxidants · doi:10.3390/antiox11010002 · Cited by 47
Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis
Bedlack, R., Joyce, N. C., Carter, G. T., Paganoni, S., & Karam, C. (2015) · Neurologic Clinics · doi:10.1016/j.ncl.2015.07.008 · Cited by 45
Mitochondrial dysfunction and Down's syndrome: Is there a role for coenzyme Q10?
Tiano, L., & Busciglio, J. A. (2011) · BioFactors · doi:10.1002/biof.184 · Cited by 45
Pharmacologic neuroprotection in ischemic brain injury after cardiac arrest
Katz, A., Brosnahan, S. B., Papadopoulos, J., Parnia, S., & Lam, J. Q. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14613 · Cited by 44
A State of the Art of Antioxidant Properties of Curcuminoids in Neurodegenerative Diseases
Silvestro, S., Sindona, C., Bramanti, P., & Mazzon, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063168 · Cited by 48
The effect of different ubiquinones on lifespan in Caenorhabditis elegans
Yang, Y.-Y., Gangoiti, J. A., Sedensky, M. M., & Morgan, P. G. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.03.003 · Cited by 42
Fernández‐Ayala, D. J. M., López‐Lluch, G., García-Valdés, M., Arroyo, A., & Navas, P. (2004) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2004.10.009 · Cited by 44
Targeting cellular energy production in neurological disorders
Baker, S. K., & Tarnopolsky, M. A. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.10.1655 · Cited by 43
Tripathi, S., Fhatima, S., Parmar, D., Singh, D. P., Mishra, S., Mishra, R., & Singh, G. (2022) · 3 Biotech · doi:10.1007/s13205-022-03171-w · Cited by 42
Mitotropic Compounds for the Treatment of Age-Related Macular Degeneration
Fehér, J., Papale, A., Mannino, G., Gualdi, L., & Gabrieli, C. B. (2003) · Ophthalmologica · doi:10.1159/000071351 · Cited by 41
Li, G., Zou, L., Cao, C., & Yang, E. S. (2005) · BioFactors · doi:10.1002/biof.5520250111 · Cited by 41
Coenzyme Q10 in the Treatment of Mitochondrial Disease
Neergheen, V., Chalasani, A., Wainwright, L., Yubero, D., Montero, R., Artuch, R., & Hargreaves, I. P. (2017) · Journal of Inborn Errors of Metabolism and Screening · doi:10.1177/2326409817707771 · Cited by 44
Mitochondrial Agents for Bipolar Disorder
Pereira, C. L., Chavarria, V., Vian, J., Ashton, M. M., Berk, M., Marx, W., & Dean, O. M. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy018 · Cited by 41
Small molecule drug discovery for Huntington's Disease
Fecke, W., Gianfriddo, M., Gaviraghi, G., Terstappen, G. C., & Heitz, F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.02.006 · Cited by 43
New advances in coenzyme Q biosynthesis
Clarke, C. F. (2000) · PROTOPLASMA · doi:10.1007/bf01282151 · Cited by 41
Rao, S. P., Sharma, N., & Kalivendi, S. V. (2020) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2020.148157 · Cited by 42
Singh, R. B., Niaz, M. A., Kumar, A., Sindberg, C., Moesgaard, S., & Littarru, G. P. (2005) · BioFactors · doi:10.1002/biof.5520250127 · Cited by 40
Recovery of solanesol from tobacco as a value-added byproduct for alternative applications
Machado, P. A., Fu, H., Kratochvil, R. J., Yuan, Y., Hahm, T., Sabliov, C. M., Wei, C., & Lo, Y. M. (2009) · Bioresource Technology · doi:10.1016/j.biortech.2009.09.009 · Cited by 40
Bioenergetic‐based neuroprotection and glaucoma
Schober, M. S., Chidlow, G., Wood, J. P. M., & Casson, R. J. (2008) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2008.01740.x · Cited by 40
Ma, D., Stokes, K., Mahngar, K., Domazet-Damjanov, D., Sikorska, M., & Pandey, S. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.07.004 · Cited by 39
Progression of intervention-focused research for Gulf War illness
Chester, J. E., Rowneki, M., Van Doren, W., & Helmer, D. A. (2019) · Military Medical Research · doi:10.1186/s40779-019-0221-x · Cited by 38
Belousova, M. A., Токарева, О. Г., Gorodetskaya, E. A., Каленикова, Е. И., & Os, M. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000320 · Cited by 39
Huntington's disease: progress and potential in the field
Stack, E. C., & Ferrante, R. J. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.12.1933 · Cited by 39
Understanding and managing metabolic dysfunction in Amyotrophic Lateral Sclerosis
Blasco, H., Lanznaster, D., Veyrat‐Durebex, C., Hergesheimer, R. C., Vourc’h, P., Maillot, F., Andres, C. R., Pradat, P., & Corcia, P. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1788389 · Cited by 37
Mitochondria-Targeted Compounds to Assess and Improve Human Sperm Function
Escada‐Rebelo, S., Cristo, M. I., Ramalho‐Santos, J., & Amaral, S. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0238 · Cited by 40
Medical treatment of Parkinson’s disease
Fahn, S. (1998) · Journal of Neurology · doi:10.1007/pl00007742 · Cited by 38
Jonassen, T., Davis, D. E., Larsen, P. L., & Clarke, C. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308760200 · Cited by 37
Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis
Phan, K., He, Y. Z., Bhatia, S., Pickford, R., McDonald, G., Mazumder, S., Timmins, H. C., Hodges, J. R., Piguet, O., Dzamko, N. L., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac340 · Cited by 36
Molecular Mechanisms Underlying Muscle Wasting in Huntington’s Disease
Bozzi, M., & Sciandra, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218314 · Cited by 38
Polyisoprenoid Epoxides Stimulate the Biosynthesis of Coenzyme Q and Inhibit Cholesterol Synthesis
Bentinger, M., Tekle, M., Brismar, K., Chojnacki, T., Świeżewska, E., & Dallner, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710202200 · Cited by 36
Park, J., Kim, M., Lee, H. J., Jang, A., Min, J., & Kim, Y. (2012) · Biomacromolecules · doi:10.1021/bm3012264 · Cited by 36
Beal, M. F. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05575.x · Cited by 37
Self-citationDistribution of Coenzyme Q Homologues in Brain
Albano, C. B., Muralikrishnan, D., & Ebadi, M. (2002) · Neurochemical Research · doi:10.1023/a:1015591628503 · Cited by 36
Al-Khayri, J. M., Ravindran, M., Banadka, A., Devaiah, V. C., Priya, K., Nagella, P., & Kukkemane, K. (2024) · Pharmaceuticals · doi:10.3390/ph17101391 · Cited by 42
New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders
Wilkins, H., & Morris, J. K. (2017) · Current Pharmaceutical Design · doi:10.2174/1381612822666161230144517 · Cited by 34
Mitochondrial and Redox-Based Therapeutic Strategies in Huntington's Disease
Fão, L., & Rego, A. C. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.8004 · Cited by 37
Coenzyme Q and protein/lipid oxidation in a BSE-infected transgenic mouse model
Martin, S. F., Burón, I., Espinosa, J. C., Castilla, J., Villalba, J. M., & Torres, J. M. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.005 · Cited by 35
Hickey, M. A., Zhu, C., Medvedeva, V. P., Franich, N. R., Levine, M. S., & Chesselet, M. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.10.007 · Cited by 35
Zahiri, H. S., Noghabi, K. A., & Shin, Y. C. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-006-0524-1 · Cited by 34
Migliore, L. (2003) · Mutagenesis · doi:10.1093/mutage/geg036 · Cited by 34
Mao, G., Kraus, G. A., Kim, I., Spurlock, M. E., Bailey, T. B., & Beitz, D. C. (2011) · British Journal Of Nutrition · doi:10.1017/s0007114510005830 · Cited by 35
Nicolson, G. L. (2005) · Pathology & Oncology Research · doi:10.1007/bf02893390 · Cited by 34
Blood Concentration of Coenzyme Q10 Increases in Rats When Esterified Forms Are Administered
Turunen, M., Appelkvist, E., Sindelar, P. J., & Dallner, G. (1999) · Journal of Nutrition · doi:10.1093/jn/129.12.2113 · Cited by 34
Monro, J. A., & Puri, B. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0928-9 · Cited by 35
Wainwright, L., Hargreaves, I. P., Georgian, A. R., Turner, C., Dalton, R. N., Abbott, N. J., Heales, S., & Preston, J. E. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103236 · Cited by 36
Zhang, S., Zhao, J., Quan, Z., Li, H., & Qing, H. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.853911 · Cited by 35
Yen, D. H. T., Chan, J. Y. H., Huang, C. I., Lee, C. H., Chan, S. H. H., & Chang, A. Y. (2005) · Shock · doi:10.1097/01.shk.0000156673.44063.e8 · Cited by 33
Lone, Y., Bhide, M., & Koiri, R. K. (2017) · Food and Chemical Toxicology · doi:10.1016/j.fct.2017.02.018 · Cited by 32
Copper-ATSM as a Treatment for ALS: Support from Mutant SOD1 Models and Beyond
Nikseresht, S., Hilton, J. B. W., Kysenius, K., Liddell, J. R., & Crouch, P. J. (2020) · Life · doi:10.3390/life10110271 · Cited by 32
One Universal Common Endpoint in Mouse Models of Amyotrophic Lateral Sclerosis
Solomon, J. A., Tarnopolsky, M. A., & Hamadeh, M. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020582 · Cited by 32
Coenzyme Q10 protects neural stem cells against hypoxia by enhancing survival signals
Park, J., Park, H.-H., Choi, H., Kim, Y. S., Yu, H., Lee, K., Lee, Y., Kim, S. H., & Koh, S. (2012) · Brain Research · doi:10.1016/j.brainres.2012.08.025 · Cited by 32
The Effect of Co-Enzyme Q10 on Acute Liver Damage in Rats, a Biochemical and Pathological Study
Ashkani‐Esfahani, S., Esmaeilzadeh, E., Bagheri, F., Emami, Y., & Farjam, M. (2013) · Hepatitis Monthly · doi:10.5812/hepatmon.13685 · Cited by 32
Metadata
- Authors
- Matthews, R. T., Yang, L., Browne, S., Baik, M., & Beal, M. F.
- Affiliations
- Harvard University (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1998-07-21
- Volume
- 95
- Issue
- 15
- Pages
- 8892-8897
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC21173
- OpenAlex
- W2100454943
- Cited by
- 557
- References
- 49
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 17 · 2023: 19 · 2022: 19 · 2021: 24 · 2020: 26 · 2019: 18 · 2018: 15 · 2017: 15 · 2016: 16 · 2015: 13 · 2014: 19 · 2013: 22 · 2012: 20
- FWCI
- 6.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5p01ns031579-05)
- National Institute on Aging (P01 AG 12992, P01AG012992)
- National Institute of Neurological Disorders and Stroke (NS 16367, NS31579, P50NS016367)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- coenzyme Q10, cerebral cortex, neuroprotection, 3-nitropropionic acid, striatal lesions, amyotrophic lateral sclerosis, transgenic mouse model, lifespan, neurodegenerative diseases, electron transport chain, free radical scavenging, oral administration
- MeSH terms
- Administration, Oral, Animals, Brain, Coenzymes, Humans, Male, Mice, Transgenic, Mitochondria, Rats, Inbred F344, Superoxide Dismutase, Ubiquinone, Rats, Sprague-Dawley, Neuroprotective Agents, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review